Jay S Epstein (Jay Epstein)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Sickle Cell Disease

Decision Making

Top Venues

US Food and Drug Administration

This page only lists publications with an associated author ORCID identifier.

Affiliation History

US Food and Drug Administration Oct 04 1981

United States

Senior Advisor for International Blood Regulatory Affairs :: Center for Biologics Evaluation and Research

Publications

Thierry Burnouf, Jay S Epstein, Jean-Claude Faber, Willem Martin Smid, null null
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries. Vox sanguinis (2023)
Thierry Burnouf, Jay S Epstein, Jean-Claude Faber, Willem Martin Smid
Stepwise access to safe plasma proteins in resource-constrained countries: Local production and pathways to fractionation-Report of an International Society of Blood Transfusion Workshop. Vox sanguinis 117 (6) (2022)
Jay S Epstein, Willem Martin Smid, Silvano Wendel, Daniel Somuah, Thierry Burnouf
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections. NPJ vaccines 5 (1) (2020)
Mart P Janssen, Claudius Micha Nübling, François-Xavier Lery, Yuyun S Maryuningsih, Jay S Epstein
A WHO tool for risk-based decision making on blood safety interventions. Transfusion 61 (2) (2020)